Bioinformatic analysis of primary endothelial cell gene array data illustrated by the analysis of transcriptome changes in endothelial cells exposed to VEGF-A and PlGF
Cite this article as: Schoenfeld, J., Lessan, K., Johnson, N. et al. Angiogenesis (2004) 7: 143. doi:10.1007/s10456-004-1677-0 Abstract
We recently published a review in this journal describing the design, hybridisation and basic data processing required to use gene arrays to investigate vascular biology (Evans etal. Angiogenesis 2003; 6: 93--104). Here, we build on this review by describing a set of powerful and robust methods for the analysis and interpretation of gene array data derived from primary vascular cell cultures. First, we describe the evaluation of transcriptome heterogeneity between primary cultures derived from different individuals, and estimation of the false discovery rate introduced by this heterogeneity and by experimental noise. Then, we discuss the appropriate use of Bayesian
t-tests, clustering and independent component analysis to mine the data. We illustrate these principles by analysis of a previously unpublished set of gene array data in which human umbilical vein endothelial cells (HUVEC) cultured in either rich or low-serum media were exposed to vascular endothelial growth factor (VEGF)-A 165 or placental growth factor (PlGF)-1 131. We have used Affymetrix U95A gene arrays to map the effects of these factors on the HUVEC transcriptome. These experiments followed a paired design and were biologically replicated three times. In addition, one experiment was repeated using serial analysis of gene expression (SAGE). In contrast to some previous studies, we found that VEGF-A and PlGF consistently regulated only small, non-overlapping and culture media-dependant sets of HUVEC transcripts, despite causing significant cell biological changes. bioinformatics endothelial gene array PlGF VEGF-A References
Yang YH, Speed T. Design issues for cDNA microarray experiments. Nat Rev Genet 2002; 3: 579–88.
Jovanovic BD, Bergan RC, Kibbe WA. Some aspects of analysis of gene array data. Cancer Treat Res 2002; 113: 71–89.
Carmeliet P, Ferreira V, Breier G et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380: 435–9.
Ferrara N, Carver-Moore K, Chen H et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380: 439–42.
Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2002; 2: 795–803.
Willett CG, Boucher Y, Di Tomaso E et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 2004; 10: 145–7.
Symes JF, Losordo DW, Vale PR et al. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg 1999; 68: 830–6; discussion 836–7.
Simovic D, Isner JM, Ropper AH et al. Improvement in chronic ischemic neuropathy after intramuscular phVEGF165 gene transfer in patients with critical limb ischemia. Arch Neurol 2001; 58: 761–8.
Carmeliet P, Moons L, Luttun A et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001; 7: 575–83.
Autiero M, Waltenberger J, Communi D et al. Role of PlGF in the intra-and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 2003; 9: 936–43.
Bussolati B, Dunk C, Grohman M et al. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol 2001; 159: 993–1008.
Abe M, Sato Y. cDNA microarray analysis of the gene expression profile of VEGF-activated human umbilical vein endothelial cells. Angiogenesis 2001; 4: 289–98.
Vasile E, Tomita Y, Brown LF et al. Differential expression of thymosin ta-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: Evidence for senescent endothelial cells in vivo at sites of atherosclerosis. FASEB J 2001; 15: 458–66.
Jih YJ, Lien WH, Tsai WC et al. Distinct regulation of genes by bFGF and VEGF-A in endothelial cells. Angiogenesis 2001; 4: 313–21.
Weston GC, Haviv I, Rogers PA. Microarray analysis of VEGFresponsive genes in myometrial endothelial cells. Mol Hum Reprod 2002; 8: 855–63.
Yang S, Toy K, Ingle G et al. Vascular endothelial growth factorinduced genes in human umbilical vein endothelial cells: relative roles of KDR and Flt-1 receptors. Arterioscler Thromb Vasc Biol 2002; 22: 1797–803.
Zhang H-T, Gorn M, Smith KA et al. Transcriptional profiling of human microvascular endothelial cells in the proliferating and quiescent state using cDNA arrays. Angiogenesis 1999; 3: 211–9.
Liu D, Jia H, Holmes DI et al. Vascular endothelial growth factorregulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1. Arterioscler Thromb Vasc Biol 2003; 23: 2002–7.
Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745–56.
Evans AL, Sharkey AS, Saidi S et al. Generation and use of a tailored gene array to investigate vascular biology. Angiogenesis 2003; 6: 93–104.
Long AD, Mangalam HJ, Chan BY et al. Improved statistical inference from DNA microarray data using analysis of variance and a Bayesian statistical framework. Analysis of global gene expression in Escherichia coli K12. J Biol Chem 2001; 276: 19937–44.
Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116–21.
Saidi SA, Holland CM, Kreil DP et al. Independent Component Analysis is a valid model for microarray analysis in endometrial cancer. Oncogene 2004; in press.
Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. Serial analysis of gene expression. Science 1995; 270: 484–7.
Johnson N, Sengupta S, Lessan K et al. Endothelial Cells preparing to die by apoptosis initiate a program of transcriptome and glycome regulation. FASEB J. 2003; 18: 188–190.
Ho M, Yang E, Matcuk G et al. Identification of endothelial cell genes by combined database mining and microarray analysis. Physiol Genomics 2003; 13: 249–62.
Clauss M, Gerlach M, Gerlach H et al. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 1990; 172: 1535–45.
Lu M, Perez VL, Ma N et al. VEGF increases retinal vascular ICAM-1 expression in vivo. Invest Ophthalmol Vis Sci 1999; 40: 1808–12.
Pepper MS, Ferrara N, Orci L, Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 1991; 181: 902–6.
Unemori EN, Ferrara N, Bauer EA, Amento EP. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 1992; 153: 557–62.
Gerber HP, Dixit V, Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 1998; 273: 13313–6.
Marumo T, Schini-Kerth VB, Busse R. Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 1999; 48: 1131–7.
Kim I, Moon SO, Kim SH, et al. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factorkappa B activation in endothelial cells. J Biol Chem 2001; 276: 7614–20.
Google Scholar Copyright information
© Kluwer Academic Publishers 2004